169 related articles for article (PubMed ID: 34300343)
1. Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader-Willi Syndrome: A Polish Multicentre Study.
Lecka-Ambroziak A; Wysocka-Mincewicz M; Doleżal-Ołtarzewska K; Zygmunt-Górska A; Wędrychowicz A; Żak T; Noczyńska A; Birkholz-Walerzak D; Stawerska R; Hilczer M; Obara-Moszyńska M; Rabska-Pietrzak B; Gołębiowska E; Dudek A; Petriczko E; Szalecki M; On Behalf Of The Polish Coordination Group For rhGH Treatment
J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300343
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Genotype and Perinatal Period, Time of Diagnosis and Anthropometric Data before Commencement of Recombinant Human Growth Hormone Treatment in Polish Patients with Prader-Willi Syndrome.
Lecka-Ambroziak A; Wysocka-Mincewicz M; Doleżal-Ołtarzewska K; Zygmunt-Górska A; Żak T; Noczyńska A; Birkholz-Walerzak D; Stawerska R; Hilczer M; Obara-Moszyńska M; Rabska-Pietrzak B; Gołębiowska E; Dudek A; Petriczko E; Szalecki M; On Behalf Of The Polish Coordination Group For rhGH Treatment
Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33925106
[TBL] [Abstract][Full Text] [Related]
3. Premature Adrenarche in Children with Prader-Willi Syndrome Treated with Recombinant Human Growth Hormone Seems to Not Influence the Course of Central Puberty and the Efficacy and Safety of the Therapy.
Lecka-Ambroziak A; Wysocka-Mincewicz M; Marszałek-Dziuba K; Rudzka-Kocjan A; Szalecki M
Life (Basel); 2020 Oct; 10(10):. PubMed ID: 33050529
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
Yang A; Choi JH; Sohn YB; Eom Y; Lee J; Yoo HW; Jin DK
Orphanet J Rare Dis; 2019 Sep; 14(1):216. PubMed ID: 31511031
[TBL] [Abstract][Full Text] [Related]
5. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
[TBL] [Abstract][Full Text] [Related]
6. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.
Scheermeyer E; Harris M; Hughes I; Crock PA; Ambler G; Verge CF; Bergman P; Werther G; Craig ME; Choong CS; Davies PSW;
Growth Horm IGF Res; 2017 Jun; 34():1-7. PubMed ID: 28427039
[TBL] [Abstract][Full Text] [Related]
7. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
8. Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition.
Damen L; Donze SH; Kuppens RJ; Bakker NE; de Graaff LCG; van der Velden JAEM; Hokken-Koelega ACS
Orphanet J Rare Dis; 2020 Jun; 15(1):163. PubMed ID: 32580778
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis.
Sanchez-Ortiga R; Klibanski A; Tritos NA
Clin Endocrinol (Oxf); 2012 Jul; 77(1):86-93. PubMed ID: 22117629
[TBL] [Abstract][Full Text] [Related]
11. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
12. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
Cavallo L; Gurrado R; Zecchino C; Manolo F; De Sanctis V; Cisternino M; Caruso-Nicoletti M; Galati M
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():845-9. PubMed ID: 10091155
[TBL] [Abstract][Full Text] [Related]
13. Management of Prader-Willi Syndrome (PWS) in adults - what an endocrinologist needs to know. Recommendations of the Polish Society of Endocrinology and the Polish Society of Paediatric Endocrinology and Diabetology.
Góralska M; Bednarczuk T; Rosłon M; Libura M; Szalecki M; Hilczer M; Stawerska R; Smyczyńska J; Karbownik-Lewińska M; Walczak M; Lewiński A
Endokrynol Pol; 2018; 69(4):. PubMed ID: 30209801
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation.
Takeda A; Cooper K; Bird A; Baxter L; Frampton GK; Gospodarevskaya E; Welch K; Bryant J
Health Technol Assess; 2010 Sep; 14(42):1-209, iii-iv. PubMed ID: 20849734
[TBL] [Abstract][Full Text] [Related]
15. Early start of growth hormone is associated with positive effects on auxology and metabolism in Prader-Willi-syndrome.
Magill L; Laemmer C; Woelfle J; Fimmers R; Gohlke B
Orphanet J Rare Dis; 2020 Oct; 15(1):283. PubMed ID: 33046090
[TBL] [Abstract][Full Text] [Related]
16. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
[TBL] [Abstract][Full Text] [Related]
17. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
18. Benefit of early commencement of growth hormone therapy in children with Prader-Willi syndrome.
Nyunt O; Harris M; Hughes I; Huynh T; Davies PS; Cotterill AM
J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1151-8. PubMed ID: 20333875
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome].
Li J; Wu W; Liang Y; Luo XP
Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):866-870. PubMed ID: 30392213
[No Abstract] [Full Text] [Related]
20. Sleep-related breathing disorders in patients with Prader-Willi syndrome depending on the period of growth hormone treatment.
Lecka-Ambroziak A; Jędrzejczak M; Wysocka-Mincewicz M; Szalecki M
Endokrynol Pol; 2017; 68(6):676-681. PubMed ID: 29022650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
